Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	929.79M -5.6%
Revenue (ttm)	200.23M +12.0%
Net Income	-59.24M
EPS	-0.60
Shares Out	99.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,352
Average Volume	148,616
Open	9.37
Previous Close	9.36
Day's Range	9.29 - 9.71
52-Week Range	8.08 - 18.32
Beta	0.76
RSI	54.79
Earnings Date	Apr 15, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 122
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.